AxoGen Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.69 |
Market Cap |
$779.79 M |
Shares Outstanding |
39.21 M |
Public Float |
34.88 M |
Address |
13631 Progress Boulevard Alachua Florida 32615 United States |
Employees | - |
Website | http://www.axogeninc.com |
Updated | 07/08/2019 |
AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provide products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. |